Bio-Rad Laboratories is likely to maintain an 80% market sha...
Bio-Rad Laboratories is likely to maintain an 80% market share in digital PCR products due to extensive offering and embracing continuous investment. Bio-Techne's extensive product offerings and the growth of its analytical instruments business are likely to drive its growth. For IQVIA, sales growth is primarily expected from managing its existing backlog.
Bio-Rad, IQVIA, Bio-Techne Among Top Picks at Credit Suisse
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment